Latus
PrivateLast Round
Series A
Extension
May 4, 2026
Total Funding Raised
$140M
Company Overview
Latus Bio is a biotechnology company focused on developing curative medicines for neurological diseases through innovative non-human-primate-based discovery methods that help doctors pinpoint brain-region-specific capsids.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Latus Comps
Public and private peers based on sector, stage, and business model.
Latus Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | May 4, 2026 | ||||
| Series A | May 2, 2024 |
Key People
Founding team and executive leadership
Latus Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Helen's Pink Sky Foundation | Series A Extension, Series A |
| Benjamin Franklin Technology Partners | Series A Extension, Series A |
| DCVC Bio | Series A Extension, Series A |
| Gaingels | Series A, Series A Extension |
| Korea Development Bank | Series A Extension, Series A |
| BioAdvance Capital | Series A Extension, Series A |
| 8VC | Series A Extension, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 4, 2026
$97M round led by 8VC and DCVC Bio.
- Nov 3, 2025
Launched an AI/ML strategy for AAV gene therapy and added two scientific advisors.
Latus Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Latus's valuation, stock price, and market status.
